11 min listen
ACR2022 - Day 4
FromRheumnow Podcast
ratings:
Length:
15 minutes
Released:
Nov 15, 2022
Format:
Podcast episode
Description
Autoimmunity Following COVID-19 Infection
Dr. Akhil Sood discusses abstract 0795 at ACR22 Convergence.
Abstract 0795: Post-Acute COVID-19 Sequalae (PACS) with New-onset Rheumatological Complications
Best of ACR22 in PsA: Day Three
Dr. Rachel Tate discusses the best PsA content presented on day three (Monday) at ACR22 Convergence in Philadelphia, PA.
Medication Adherence intervention in SLE
Dr. Bella Mehta speaks with Dr. Kai Sun abstract 0063 at ACR22 Convergence in Philadelphia, PA.
Abstract 0063: Implementability of a SLE Medication Adherence Intervention
Peresolimab for RA: Phase 2a Results
Dr. Jonathan Kay abstract L03 at ACR22 Convergence in Philadelphia.
L03: A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis
Dr. Akhil Sood discusses abstract 0795 at ACR22 Convergence.
Abstract 0795: Post-Acute COVID-19 Sequalae (PACS) with New-onset Rheumatological Complications
Best of ACR22 in PsA: Day Three
Dr. Rachel Tate discusses the best PsA content presented on day three (Monday) at ACR22 Convergence in Philadelphia, PA.
Medication Adherence intervention in SLE
Dr. Bella Mehta speaks with Dr. Kai Sun abstract 0063 at ACR22 Convergence in Philadelphia, PA.
Abstract 0063: Implementability of a SLE Medication Adherence Intervention
Peresolimab for RA: Phase 2a Results
Dr. Jonathan Kay abstract L03 at ACR22 Convergence in Philadelphia.
L03: A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis
Released:
Nov 15, 2022
Format:
Podcast episode
Titles in the series (100)
The RheumNow Week in Review - 12 May 2017: The RheumNow Week in Review - 12 May 2017 by Dr. Cush by Rheumnow Podcast